TransMedics Group Inc (OQ:TMDX)

Business Focus: Advanced Medical Equipment & Technology

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
 
See Regulatory Filings on SEC
Company Contact
Address: 200 Minuteman Road
ANDOVER MA 01810
Tel: N/A
Website: https://www.transmedics.com
IR: See website
<
Key People
Waleed H. Hassanein
President, Chief Executive Officer, Director
Stephen Gordon
Chief Financial Officer, Treasurer, Secretary
Anil Ranganath
Senior Vice President, General Counsel, Company Secretary
Nick Corcoran
Senior Vice President - Supply Chain and Operations
Laura Damme
Vice President - Clinical Affairs
Miriam Provost
Vice President - Global Regulatory Affairs
Tamer I. Khayal
Chief Commercial Officer
   
Business Overview
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Financial Overview
For the fiscal year ended 31 December 2023, TransMedics Group Inc revenues increased from $93.5M to $241.6M. Net loss decreased 31% to $25M. Revenues reflect OCS Liver net revenue segment increase from $46.3M to $151.8M, OCS Heart net revenue segment increase of 91% to $73.1M, United States segment increase from $84M to $221.3M, All other countries segment increase of 63% to $15.4M.
Employees: 584 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $2,530M as of Dec 31, 2023
Annual revenue (TTM): $241.62M as of Dec 31, 2023
EBITDA (TTM): -$18.55M as of Dec 31, 2023
Net annual income (TTM): -$25.03M as of Dec 31, 2023
Free cash flow (TTM): -$164.88M as of Dec 31, 2023
Net Debt Last Fiscal Year: $111.39M as of Dec 31, 2023
Shares outstanding: 32,715,316 as of Jan 31, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.